No black box warning on record for Abecma

As of the latest FDA labeling reviewed, Abecma (IDECABTAGENE VICLEUCEL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Abecma medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Hypersensitivity Reactions : Monitor for hypersensitivity reactions during infusion. ( 5.5 ) • Infections : Monitor patients for signs and symptoms of infection; treat appropriately. ( 5.6 ) • Prolonged Cytopenias : Patients may exhibit prolonged Grade 3 or higher cytopenias following ABECMA infusion. Monitor blood counts prior to and after ABECMA infusion. ( 5.7 ) • H

No black box warning on record for Abecma

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Hypersensitivity Reactions : Monitor for hypersensitivity reactions during infusion. ( 5.5 ) • Infections : Monitor patients for signs and symptoms of infection; treat appropriately. ( 5.6 ) • Prolonged Cytopenias : Patients may exhibit prolonged Grade 3 or higher cytopenias following ABECMA infusion. Monitor blood counts prior to and after ABECMA infusion. ( 5.7 ) • H

Abecma Black Box Warning

No black box warning on record for Abecma

Other warnings & precautions

Abecma Black Box Warning

No black box warning on record for Abecma

Other warnings & precautions